Cymabay Therapeutics Inc [NASDAQ: CBAY] jumped around 0.01 points on Thursday, while shares priced at $32.48 at the close of the session, up 0.03%. The company report on March 4, 2024 at 8:00 AM that CymaBay Announces European Medicines Agency Accepts for Review the Marketing
Cymabay Therapeutics Inc [NASDAQ: CBAY] price surged by 0.40 percent to reach at $0.13. The company report on March 4, 2024 at 8:00 AM that CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary
Cymabay Therapeutics Inc [NASDAQ: CBAY] stock went on a downward path that fall over -0.25% on Thursday, amounting to a one-week price increase of more than 0.06%. The company report on February 28, 2024 at 4:45 PM that CymaBay Reports Fourth Quarter and Year Ended
Cymabay Therapeutics Inc [NASDAQ: CBAY] traded at a high on Monday, posting a 25.38 gain after which it closed the day’ session at $32.21. The company report on February 12, 2024 at 8:45 AM that CymaBay Announces FDA Acceptance of NDA and Priority Review for
© 2024, Powered by Smart TechOne
